| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Expression profiling by high throughput sequencing
|
Homo sapiens
|
Matthew Meier
|
|||||
| GSE218911 |
Finding genetic loci that are sensitive to demethylation to assist in the development of DNA methylation-based in vitro assay for the identification of carcinogens
|
|
|
34 | Matthew Meier | Feb 10, 2023 | ||
| GSE220238 |
DNA methylation changes from primary cultures through senescence-bypass in Syrian hamster fetal cells initially exposed to benzo[a]pyrene
|
|
|
69 | Matthew Meier | Feb 10, 2023 | ||
| GSE171360 |
CometChip® and TempO-Seq®: A high-throughput 96-well platform to measure and classify DNA damaging agents in human HepaRG™ Cells [HCC3]
|
|
|
288 | Matthew Meier | Jul 21, 2021 | ||
| GSE196372 |
Toxicity Testing in the 21st Century: An Integrated Approach to Genetic Safety Testing using the TGx-DDI Genomic Biomarker and High-Throughput CometChip® [Sequencing]
|
|
|
96 | Matthew Meier | Aug 02, 2022 | ||
| GSE211183 |
In vitro transcriptomic analyses reveal pathway perturbations, estrogenic activities, and potencies of data-poor BPA alternative chemicals
|
|
|
768 | Matthew Meier | Aug 18, 2022 | ||
| GSE145239 |
High-throughput transcriptomics assessment of 24 per- and polyfluoroalkyl substances (PFAS) in human liver spheroids
|
|
|
1201 | Matthew Meier | Nov 08, 2021 | ||
| GSE196373 |
Toxicity Testing in the 21st Century: An Integrated Approach to Genetic Safety Testing using the TGx-DDI Genomic Biomarker and High-Throughput CometChip®
|
|
|
192 | Matthew Meier | Aug 02, 2022 | ||
| GSE153320 |
Transcriptomics and relative potency assessments using Bench Mark Dose of Bisphenol A, Bisphenol S, Bisphenol F, and 3,3',5,5'-Tetrabromobisphenol A in H9 human embryonic stem cells
|
|
|
80 | Matthew Meier | Jul 19, 2021 | ||
| GSE213454 |
Application of a New Approach Methodology (NAM)-based Strategy for Genotoxicity Assessment of Data-poor Compounds
|
|
|
276 | Matthew Meier | Nov 15, 2022 | ||
| GSE241995 |
Toxicological Mechanisms and Potencies of Organophosphate Esters in KGN Human Ovarian Granulosa Cells as Revealed by High-throughput Transcriptomics
|
|
|
162 | Matthew Meier | Nov 07, 2023 | ||
| GSE271332 |
High-Throughput Transcriptomics Toxicity Assessment of Eleven Data-Poor Bisphenol A Alternatives
|
|
|
286 | Matthew Meier | Aug 26, 2024 | ||
| GSE120805 |
RNA-Seq analysis of human lens epithelial cells exposed to ionizing radiation
|
|
|
70 | Matthew Meier | Oct 04, 2018 | ||
| GSE136009 |
Flow cytometric micronucleus assay and TGx-DDI transcriptomic biomarker analysis of ten genotoxic and non-genotoxic chemicals in human HepaRG™ cells
|
|
|
39 | Matthew Meier | Feb 18, 2020 | ||
| GSE144775 |
Development and application of a high-throughput gene expression profiling of per- and polyfluoroalkyl substances (PFAS) in primary liver human spheroids to inform read-across
|
|
|
607 | Matthew Meier | Dec 22, 2020 | ||
| GSE164478 |
Development of a transcriptomic biomarker to detect histone deacetylase inhibitors (HDACi) in TK6 cells
|
|
|
128 | Matthew Meier | Apr 14, 2021 | ||
| GSE281641 |
In vitro to in vivo extrapolation modeling to facilitate the integration of transcriptomics data into genotoxicity assessment
|
|
|
161 | Matthew Meier | Nov 13, 2024 |
